GAS5 may be involved in TLR4-mediated inflammatory processes by inhibiting the activation of the mitogen activated protein kinase (MAPK) pathway, thus participating in the pathogenesis of SLE (90). The gene discussed is GAS5; the disease is systemic lupus erythematosus.